Broadview Ventures
Impact investorBoston · Seed–Late Stage · 20 people tracked
Investment thesis
Broadview Ventures pursues impact investing in the cardiovascular disease space. Its mission is to accelerate the development of promising technologies for diagnosing and treating cardiovascular disease and stroke, aiming to get new treatments to patients. The firm makes targeted investments and maintains a diversified portfolio across a range of relevant technologies.
Source: firm website, verified Aug 3, 2026.
Team · 20 people
from the firm's website & public directories
What they invest in
from 34 of 47 portfolio companiesMedical Devices ×27Healthtech ×21Biotech ×20Digital Health ×10AI & Machine Learning ×4Deep Tech ×4FemTech ×1Hardware ×1
HQs:United States×16Denmark×1Finland×1France×1
Investments · 47 tracked
founders shown can be your intro pathBy year:2022 · 22020 · 22016 · 12015 · 27 dated
HAYA Therapeutics develops precision RNA medicines that target long non-coding RNAs (lncRNAs) in the regulatory genome to reprogram disease at the level of cell state, with a lead program in cardiac fibrosis and work in obesity and metabolic disease.
AI & Machine LearningBiotechDeep TechHealthtech
Samir Ounzain(Chief Executive Officer (CEO) & Co-founder)Daniel Blessing(Chief Scientific Officer (CSO) & Co-founder)Richard Law(Chief Business Officer (CBO))Eric Adam(Chief Operating Officer (COO))Jordan Shin(Chief Medical Officer (CMO))Jérôme Andries(Chief Financial Officer (CFO))
BiotechPearland, US
Michael Hogan(Director)Mitchell Eggers(Executive Officer, Director)Robert Tucci(Director)
Aeromics is a clinical-stage biopharmaceutical company developing AER-271, an aquaporin-4 inhibitor to prevent cerebral edema (brain swelling) in severe acute ischemic stroke patients.
BiotechMedical DevicesNew Haven, US
Dr. Pelletier(Founder)Dr. Boron(Founder)Frederick Jones(Director)Paul McGuirk(Executive Officer)Walter Boron(Executive Officer, Director)George Farr(Executive Officer)
Alleviant Medical develops an investigational minimally invasive medical device using interatrial shunt therapy to treat heart failure patients, currently in FDA-approved clinical trials (ALLAY-HF and ALLAY-HFrEF).
BiotechHealthtechMedical DevicesAustin, US
Adam Berman(Executive Officer, Director)Jacob Kriegel(Executive Officer, Director)Avni Patel(Executive Officer, Director)Christopher Alex Arevalos(Executive Officer, Director)Albertien Greijdanus(Executive Officer, Director)
BoardGeoff Pardo(Director)
Antag Therapeutics develops GIP receptor antagonist therapies for obesity, diabetes, and overweight patients.
BiotechHealthtechCopenhagen, DK
Jens Juul Holst(Founder)Mette Rosenkilde(Founder)
BiotechHealthtechSt. Paul, US
Karl Vollmers(Executive Officer)John Scandurra(Executive Officer)Joshua Woolley(Executive Officer)Ryan Gladney(Executive Officer)Gary Graham(Executive Officer)Dan W. Gladney(Executive Officer, Director)
Basking Biosciences develops therapeutics for thrombosis, vascular biology, and ischemic disease.
BiotechDigital HealthHealthtechMedical DevicesCary, US
Shahid Nimjee(Co-founder, Chief Scientific Officer and Stroke Clinical Lead)inBruce Sullenger(Co-founder)Julia Owens(Executive Officer, Director, Promoter)Ryan Helon(Director)Dan Myers(Director)Richard Shea(Executive Officer, Director, Promoter)
BioKier develops oral products for managing lipids and glucose in type 2 diabetes and cardiometabolic disorders, designed to replicate the metabolic benefits of bariatric surgery through colon-targeted nutrient delivery.
BiotechHealthtechMedical Devices
Cardiosense develops the CardioTag, a noninvasive point-of-care cardiac monitoring device that measures pulmonary capillary wedge pressure to enable early detection and management of worsening heart failure across emergency, inpatient, and outpatient settings.
AI & Machine LearningDigital HealthMedical DevicesChicago, US
Omer Tolga Inan(Director)Amit K. Gupta(Executive Officer, Director)Andrew Michael Carek(Executive Officer)
BoardJeff Terrell(Director)Daniel Gottlieb(Director)
Comanche Biopharma is a biopharmaceutical company developing evidence-based therapies for preeclampsia and other life-threatening conditions of pregnancy, with a focus on maternal and neonatal health.
BiotechFemTechHealthtechConcord, US
Arthur Levin(Director)Muzammil Mansuri(Director)Paul Antinori(Executive Officer)Allison August(Executive Officer)Ann Taylor(Director)Clive Meanwell(Director)
CroíValve develops the DUO System, a minimally invasive heart valve device designed to treat tricuspid regurgitation, a common and often underdiagnosed heart condition.
HealthtechMedical Devices
Dr. Martin Quinn(Co-Founder)
Epirium Bio develops novel oral therapeutics targeting mitochondrial dysfunction and muscle diseases, particularly muscular dystrophy.
BiotechMedical DevicesSan Diego, US
Pam Taub(M.D., FACC, Founder)Alan Maisel(M.D., Founder)Francisco Villarreal(M.D., Ph.D., Founder)Jonathan Taub(Founder, Chief Executive Officer)Guillermo Ceballos(M.D., Founding Scientist)Russell J. Cox(President and CEO)
Gila Therapeutics is a clinical-stage biotech company developing topical/lingual hormone therapies (starting with Topical Lingual PYY) that activate satiety centers in the brain via a tongue-brain neural pathway without systemic exposure.
BiotechDigital HealthLongevityMinneapolis, US
Thomas J. Vasicek(Executive Officer, Director, Promoter)Jon Freeman(Executive Officer)Richard Horan(Director)Donald R. Johns(Chief Medical Officer)
BoardChristopher de Souza(Director)
Herantis Pharma is a public pharmaceutical company listed on Nasdaq First North Growth Market Finland, focused on developing therapeutic treatments.
BiotechDeep TechMedical Devices
Antti Vuolanto(CEO)
i3 develops intravascular imaging technology that combines ultrasound (IVUS) with near-infrared fluorescence (NIRF) for physicians performing percutaneous coronary intervention procedures.
Medical Devices
InfoBionic.Ai develops a remote cardiac monitoring platform called MoMe ARC that combines AI-powered ECG analysis, interchangeable biosensors, and clinical analytics to enable hospital-grade cardiac telemetry outside traditional hospital settings.
AI & Machine LearningHealthtechMedical DevicesLowell, US
Al Wiegman(Director)Carl Berke(Director)Steven Wasserman(Executive Officer)Nancy Briefs(Executive Officer, Director)Hamid Tabatabaie(Director)
BoardCaleb Winder(Director)
Ischemia Care operates a CLIA-certified laboratory that develops blood tests for stroke patients using RNA expression analysis to determine stroke cause and improve clinical outcomes.
AI & Machine LearningDigital HealthHealthtechMedical DevicesOxford, US
Jeffrey June(Executive Officer, Director)Teresa June(Executive Officer)
Lyra Therapeutics is a clinical-stage biotechnology company developing drug-eluting nasal meshes for localized treatment of chronic rhinosinusitis.
BiotechHealthtechMedical Devices
MaxWell Biomedical develops a cardiac resynchronization therapy device (CRT-A) designed to restore both sinus rhythm and atrial mechanical function in patients with atrial fibrillation, particularly those with post-surgical AF or AF combined with heart failure.
BiotechHealthtechMedical Devices
Mellitus Health automates an algorithm-based insulin dosing system for medical professionals, generating precision dosing recommendations across all standard insulin regimens and types.
Digital HealthHealthtechMedical Devices
Mayer B. Davidson(MD, former American Diabetes Association president)
Mosanna develops a nighttime nasal spray pharmaceutical treatment for obstructive sleep apnea that reactivates upper airway muscles to restore the body's natural airway control.
HealthtechMedical Devices
NuPulse Voyage is a cardiac support device designed to help heart transplant candidates improve their physical condition while awaiting transplantation.
BiotechHealthtechMedical DevicesRaleigh, US
GREG SCOTT(Director)RICHARD SHERMAN(Director)ALEX SHLYANKEVICH(Director)SONNA PATEL-RAMAN(Executive Officer)DOUGLAS ALTSCHULER(Executive Officer, Director)BRIAN NOVAK(Director)
Nyra Medical develops the CARLEN System, a transcatheter device for single-leaflet repair of functional mitral regurgitation that preserves native valve function.
BiotechDigital HealthMedical DevicesAtlanta, US
Dr. Murali Padala(Founder)Dr. Eric Sarin(Founder)Dr. Kirthana Suresh(Founder)Lori Chmura(CEO)Sai Muralidhar Padala(Executive Officer, Director)Gowri Raman(Director)
Puzzle Medical Devices develops a cardiac support device designed to improve heart and kidney function in heart failure patients through a minimally invasive 4Fr axillary approach, enabling patient mobility during treatment.
HealthtechMedical DevicesMontreal
AFTAB KHERANI(Director)PHILIPPE GENEREUX(Executive Officer)PASCAL LABRECQUE(Director)FRANCOIS TRUDEAU(Executive Officer, Director)DOUGLAS KOO(Director)DAVID PRIM(Director)
Medical Devices
Remedy Pharmaceuticals is a pharmaceutical company developing Cirara, an investigational drug studied in clinical trials for patients who have suffered a stroke.
BiotechHealthtechNew York, US
SVEN JACOBSON(Executive Officer, Director)DAVID GELIEBTER(Director)
Rocket Pharmaceuticals develops gene therapies to treat patients with rare genetic diseases, focusing on cardiovascular and hematologic disorders.
BiotechDigital HealthMedical Devices
Gaurav Shah(Co-founder & Chief Executive Officer)
BoardRoderick Wong(Director)Naveen Yalamanchi(Director)
Vectorious Medical Technologies develops implantable sensing platforms designed to deliver clinical information for patient therapies.
Digital HealthHardwareHealthtechMedical Devices
Viridian Therapeutics develops treatments for thyroid eye disease, a rare autoimmune condition affecting the eyes and orbit.
BiotechDigital HealthMedical DevicesWaltham, US
Jonathan Violin(Executive Officer, Director)Peter Harwin(Director)Tomas Kiselak(Director)
XII Medical develops neuromodulation therapies for treating obstructive sleep apnea, focusing on simplifying treatment options and improving patient outcomes.
Deep TechDigital HealthHealthtechMedical DevicesUnion City, US
Garrett Schwab(Chief Executive Officer)Shane Kreidel(Secretary and Chief Financial Officer)Zachary Eisen(Director)
BoardDuke Rohlen(Director)JD Friedland(Director)Saoussen Ben Halima(Director)
Portfolio news
latest coverage across their companiesHerantis Pharma · manilatimes.net · Jun 2, 2026
Rocket Pharma · reuters.com · Mar 27, 2026
Basking Biosciences · insightpartners.com · Jan 21, 2026
Frequently asked questions
- What stage does Broadview Ventures invest at?
- Broadview Ventures invests at the Seed, Series A, Late Stage stages.
- What sectors does Broadview Ventures focus on?
- Broadview Ventures focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is Broadview Ventures located?
- Broadview Ventures is headquartered in Boston, US.
Images
Co-investors · 10
Hatteras Venture Partners is a venture capital firm focused on early-stage life sciences and healthcare companies, backing therapeutics, diagnostics, and businesses aiming to transform healthcare delivery and innovation.
Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.
Arboretum Ventures is a Midwest-based healthcare venture capital firm that invests in early-stage healthcare startups across medical devices, life science tools and diagnostics, tech-enabled care delivery, and pharma adjacencies.
Apollo Health Ventures is a biotech-focused investor that combines traditional funding with venture building to back transformative healthcare and longevity companies in Europe and the US.
SOSV is a deep tech venture capital firm that makes first-check pre-seed investments and follow-on rounds in startups focused on human and planetary health, providing lab space and hands-on support at its US locations.
Polaris Partners is a venture capital firm that partners with biotech and healthcare entrepreneurs to build transformational companies.
Pillar VC is an early-stage venture capital firm that partners with technical founders at inception to build companies from breakthrough technology.
Advent Life Sciences is a trans-Atlantic venture capital firm investing in early and mid-stage life sciences companies across the UK, Europe and the USA.
Humboldt Fund focuses exclusively on synthetic biology as a general-purpose technology to remake chemicals, materials, foods, and medicines, led by a UCSF-trained PhD cell biologist who brings deep research background directly into fund leadership. The fund backs "bio revolution" companies that replace conventional industrial inputs with biology-based alternatives through a concentrated portfolio of category-defining names like Geltor, NotCo, Meatable, and MycoWorks, while investing globally across Latin America and Europe rather than maintaining a US-centric focus.
A venture capital firm that combines clinical expertise with business acumen to invest in medical technology companies. The firm has a track record spanning over two decades of identifying transformational healthcare innovations.
Firms observed investing alongside Broadview Ventures, from public investor directories. Shared companies are the overlap with Broadview Ventures's recorded portfolio.
Similar investors
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
The JDRF T1D Fund is a venture philanthropy investor focused on type 1 diabetes (T1D), backing companies developing disease-modifying therapies and cures for the condition.
Gilde Healthcare is a specialist investment firm managing healthcare and climate-focused funds across venture & growth, and private equity strategies with a transatlantic team of sector specialists.